A phase 1/2 study of chemosensitization with plerixafor plus G-CSF in relapsed or refractory acute myeloid leukemia

G. L. Uy; M. P. Rettig; R. M. Stone; M. Y. Konopleva; M. Andreeff; K. McFarland; W. Shannon; T. R. Fletcher; T. Reineck; W. Eades; K. Stockerl-Goldstein; C. N. Abboud; M. A. Jacoby; P. Westervelt; J. F. Di Persio

doi:10.1038/bcj.2017.21

A phase 1/2 study of chemosensitization with plerixafor plus G-CSF in relapsed or refractory acute myeloid leukemia

G. L. Uy, M. P. Rettig, R. M. Stone, M. Y. Konopleva, M. Andreeff, K. McFarland, W. Shannon, T. R. Fletcher, T. Reineck, W. Eades, K. Stockerl-Goldstein, C. N. Abboud, M. A. Jacoby, P. Westervelt, J. F. Di Persio

Leukemia

Research output: Contribution to journal › Letter › peer-review

39 Scopus citations

Original language	English (US)
Article number	e542
Journal	Blood cancer journal
Volume	7
Issue number	3
DOIs	https://doi.org/10.1038/bcj.2017.21
State	Published - Mar 10 2017

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1038/bcj.2017.21

Cite this

Uy, G. L., Rettig, M. P., Stone, R. M., Konopleva, M. Y., Andreeff, M., McFarland, K., Shannon, W., Fletcher, T. R., Reineck, T., Eades, W., Stockerl-Goldstein, K., Abboud, C. N., Jacoby, M. A., Westervelt, P., & Di Persio, J. F. (2017). A phase 1/2 study of chemosensitization with plerixafor plus G-CSF in relapsed or refractory acute myeloid leukemia. Blood cancer journal, 7(3), Article e542. https://doi.org/10.1038/bcj.2017.21

Uy, GL, Rettig, MP, Stone, RM, Konopleva, MY, Andreeff, M, McFarland, K, Shannon, W, Fletcher, TR, Reineck, T, Eades, W, Stockerl-Goldstein, K, Abboud, CN, Jacoby, MA, Westervelt, P & Di Persio, JF 2017, 'A phase 1/2 study of chemosensitization with plerixafor plus G-CSF in relapsed or refractory acute myeloid leukemia', Blood cancer journal, vol. 7, no. 3, e542. https://doi.org/10.1038/bcj.2017.21

@article{f10b03597b4544e79b951f451c0e6a7e,

title = "A phase 1/2 study of chemosensitization with plerixafor plus G-CSF in relapsed or refractory acute myeloid leukemia",

author = "Uy, {G. L.} and Rettig, {M. P.} and Stone, {R. M.} and Konopleva, {M. Y.} and M. Andreeff and K. McFarland and W. Shannon and Fletcher, {T. R.} and T. Reineck and W. Eades and K. Stockerl-Goldstein and Abboud, {C. N.} and Jacoby, {M. A.} and P. Westervelt and {Di Persio}, {J. F.}",

year = "2017",

month = mar,

day = "10",

doi = "10.1038/bcj.2017.21",

language = "English (US)",

volume = "7",

journal = "Blood cancer journal",

issn = "2044-5385",

publisher = "Nature Publishing Group",

number = "3",

}

TY - JOUR

T1 - A phase 1/2 study of chemosensitization with plerixafor plus G-CSF in relapsed or refractory acute myeloid leukemia

AU - Uy, G. L.

AU - Rettig, M. P.

AU - Stone, R. M.

AU - Konopleva, M. Y.

AU - Andreeff, M.

AU - McFarland, K.

AU - Shannon, W.

AU - Fletcher, T. R.

AU - Reineck, T.

AU - Eades, W.

AU - Stockerl-Goldstein, K.

AU - Abboud, C. N.

AU - Jacoby, M. A.

AU - Westervelt, P.

AU - Di Persio, J. F.

PY - 2017/3/10

Y1 - 2017/3/10

UR - http://www.scopus.com/inward/record.url?scp=85015204433&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015204433&partnerID=8YFLogxK

U2 - 10.1038/bcj.2017.21

DO - 10.1038/bcj.2017.21

M3 - Letter

C2 - 28282031

AN - SCOPUS:85015204433

SN - 2044-5385

VL - 7

JO - Blood cancer journal

JF - Blood cancer journal

IS - 3

M1 - e542

ER -

A phase 1/2 study of chemosensitization with plerixafor plus G-CSF in relapsed or refractory acute myeloid leukemia

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this